Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
出版年份 2013 全文链接
标题
Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 109, Issue 10, Pages 2685-2695
出版商
Springer Nature
发表日期
2013-10-18
DOI
10.1038/bjc.2013.636
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Translating TRAIL-receptor targeting agents to the clinic
- (2012) Martha W. den Hollander et al. CANCER LETTERS
- Kinetics in Signal Transduction Pathways Involving Promiscuous Oligomerizing Receptors Can Be Determined by Receptor Specificity: Apoptosis Induction by TRAIL
- (2012) Eva Szegezdi et al. MOLECULAR & CELLULAR PROTEOMICS
- Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist
- (2012) V. Subbiah et al. MOLECULAR CANCER THERAPEUTICS
- Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells
- (2011) Liang-Cheng Li et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis
- (2011) E W Duiker et al. BRITISH JOURNAL OF CANCER
- Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer
- (2011) Jean-Charles Soria et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants
- (2011) C R Reis et al. Cell Death & Disease
- Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
- (2011) R Koster et al. Cell Death & Disease
- LBY135, a novel anti-DR5 agonistic antibody induces tumor cell-specific cytotoxic activity in human colon tumor cell lines and xenografts
- (2010) Jing Li et al. DRUG DEVELOPMENT RESEARCH
- The role of c-FLIPL in ovarian cancer: Chaperoning tumor cells from immunosurveillance and increasing their invasive potential
- (2010) Ahmed El-Gazzar et al. GYNECOLOGIC ONCOLOGY
- Effect of TRA-8 Anti-Death Receptor 5 Antibody in Combination With Chemotherapy in an Ex Vivo Human Ovarian Cancer Model
- (2010) Peter J. Frederick et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase I Dose-Escalation Study of Recombinant Human Apo2L/TRAIL, a Dual Proapoptotic Receptor Agonist, in Patients With Advanced Cancer
- (2010) Roy S. Herbst et al. JOURNAL OF CLINICAL ONCOLOGY
- Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies
- (2010) Inge A M de Graaf et al. Nature Protocols
- Enhancement of Antitumor Properties of rhTRAIL by Affinity Increase toward Its Death Receptors†
- (2009) Carlos R. Reis et al. BIOCHEMISTRY
- Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells
- (2009) Takeshi Hori et al. CANCER LETTERS
- Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model
- (2009) E. W. Duiker et al. CLINICAL CANCER RESEARCH
- Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
- (2009) Sebastian Bauer et al. EUROPEAN UROLOGY
- The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer
- (2009) Evelien W. Duiker et al. GYNECOLOGIC ONCOLOGY
- TRAIL receptor signalling and modulation: Are we on the right TRAIL?
- (2008) Devalingam Mahalingam et al. CANCER TREATMENT REVIEWS
- Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5
- (2008) C Adams et al. CELL DEATH AND DIFFERENTIATION
- A robustex vivomodel for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants
- (2008) Brigitte M.T. Hougardy et al. INTERNATIONAL JOURNAL OF CANCER
- DR4-selective Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Variants Obtained by Structure-based Design
- (2008) Vicente Tur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started